Market Place
Sourcing Support
FDA Issues Form 483 to Patheon Italia S.p.A
27 Nov 2024 //
FDA
Patheon`s Generic Ibuprofen Receives Approval in the U.S.
13 Feb 2024 //
FDA
Patheon`s Generic Naproxen Sodium Receives Approval in the U.S.
10 Jan 2023 //
FDA
Neuvivo Begins Manufacture of ALS Treatment NP001
11 May 2022 //
CONTRACTPHARMA
Oxcia contracts Patheon for manufacturing & further strengthens the organization
17 Jan 2022 //
CISION
Patheon to Manufacture FDA-Approved Nasal Spray
17 Jul 2020 //
CONTRACTPHARMA
Tergus Pharma to become full-fledged CDMO with new manufacturing facility
10 Jun 2019 //
FIERCE PHARMA
Thermo Fisher picks up mass spec software developer HighChem
06 Jun 2019 //
FIERCE BIOTECH
Cantargia, Patheon Biologics Sign Supply Agreement
20 May 2019 //
CONTRACT PHARMA
Overview of comments received on Ibuprofen 200 – 800 mg IR formulations
03 Dec 2018 //
EMA
Enforcement Report - Week of March 14, 2018
14 Mar 2018 //
FDA
Enforcement Report - Week of March 7, 2018
07 Mar 2018 //
FDA
Naproxen Sodium : Patheon Softgels V. Apotex
02 Jan 2018 //
PATENT LITIGATION
Evoke’s experience with Thermo wins Patheon nasal metoclopramide contract
13 Nov 2017 //
IN PHARMATECHNOLOGIST
More than 100 CMOs fully configured on TraceLink Life Sciences Cloud
20 Oct 2017 //
MANUFACTURING CHEMIST
Planning teams forming as Thermo Fisher completes $7.2bn Patheon acquisition
18 Sep 2017 //
OUTSOURCING
Patheon joins Thermo Fisher with completion of $7.2B buyout
01 Sep 2017 //
FIERCE PHARMA
Anvisa grants registration to drug Spinraza
26 Aug 2017 //
ANVISA
Thermo Fisher Scientific receives regulatory approvals - acquisition of Patheon
24 Aug 2017 //
PHARMABIZ
Generic Drugs Stock Performance Review Patheon, Zoetis, Ironwood & Medicines
21 Aug 2017 //
PR NEWSWIRE
Thermo Fisher pulls in funding as it preps for Patheon acquisition
15 Aug 2017 //
OUTSOURCING PHARMA
Patheon invests in 4 sites ahead of buyout by Thermo Fisher
05 Jul 2017 //
FIERCE PHARMA
Patheon to spend $45m on manufacturing plants ahead of Thermo takeover
01 Jul 2017 //
IN PHARMATECHNOLOGIST
Tetraphase hires Patheon to make its synthetic antibiotic eravacycline
23 Jun 2017 //
IN PHARMATECHNOLOGIST
After Bagging Patheon for $7.2 Billion, This Could be Thermo Fisher Scientific
14 Jun 2017 //
BIOSPACE
Patheon to manufacture amyloidosis antibody treatment for Caelum
03 Jun 2017 //
BIOPHARMA
Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn
16 May 2017 //
IN PHRAMATECHNOLOGIST
Patheon spends $26m to up capacity for liquid and freeze-dried drugs
09 May 2017 //
IN PHARMATECHNOLOGIST
Patheon says buyout of Roche API plant gives it border tax protection
21 Mar 2017 //
FIERCE PHARMA
Keryx: Patheon and Norwich sites will ensure supply of iron-based Auryxia
07 Mar 2017 //
IN PHARMATECHNOLOGIST
Enforcement Report - Week of February 22, 2017
22 Feb 2017 //
FDA
Teva recalls 500,000 units of diabetes drug manufactured by Patheon
17 Feb 2017 //
FIERCE PHARMA
Is the return of the one-stop-shop model just a CMO marketing ploy?
16 Feb 2017 //
IN PHARMATECHNOLOGIST
Roche: `Largest biomanufacturing capacity across the industry` to get bigger
07 Feb 2017 //
IN PHARMATECHNOLOGIST
Patheon well placed if Trump succeeds in bringing manufacturing home, analyst
02 Feb 2017 //
IN PHARMATECHNOLOGIST
Lonza Bulks up with $5.5B Deal for Capsugel
16 Dec 2016 //
FIERCE PHARMA
Lonza Confirms Interest in Capsugel Takeover
13 Dec 2016 //
IN PHARMATECHNOLOGIST
Roche to Sell U.S. Plant to Patheon, Saving About 200 Jobs
29 Nov 2016 //
FIERCE PHARMA
Hurricane and fire related shutdowns have cost Patheon $15m
14 Nov 2016 //
IN PHARMATECHNOLOGIST
Keryx solves supply issues as FDA approves Patheon to produce kidney drug
10 Nov 2016 //
FIERCE PHARMA
Endo`s Par recalls half a million birth control pills made by Patheon
02 Nov 2016 //
FIERCE PHARMA
Patheon Contracted to Make Second Drug by Age-Related Diseases Firm Biophytis
26 Oct 2016 //
IN PHARMATECHNOLOGIST
Patheon Announces The Retirement Of Stuart Grant
11 Oct 2016 //
PRESS RELEASE
Actavis recalls pills made by Patheon
18 Aug 2016 //
FIERCE MANUFACTURING
API and drug maker Patheon will begin trading on the NYSE under the symbol PTHN
21 Jul 2016 //
IN PHARMATECHNOLOGIST
Patheon Names Patrick Glaser Senior VP for Small Molecule API Business
05 Jul 2016 //
PRESS RELEASE
Patheon Appoints Michel Lagarde As President
31 May 2016 //
PRESS RELEASE
Flexible Manufacturing Can Help Pharmaceutical Industry Avoid High Costs
15 Mar 2016 //
PRESS RELEASE
Patheon signs flexible manufacturing agreement with Amgen
14 Mar 2016 //
CPHI-ONLINE
Patheon Customers saves time with new filling technology
17 Feb 2016 //
PRESS RELEASE
Patheon Appoints Andrew G. Long as Senior VP & Global Business Controller
08 Feb 2016 //
PRESS RELEASE
Patheon Appoints Leader for Biologics
02 Feb 2016 //
PRESS RELEASE
Patheon Unveils New Brand and Identity
28 Sep 2015 //
PRESS RELEASE
Expanding Patheon Begins Hiring Hundreds at Eastern North Carolina Plant
28 Sep 2015 //
BIOSPACE
Patheon, DPx unload chemical operations to tighten focus on pharma
23 Jul 2015 //
FIERCE PHARMA MANUFACTURING
Ardian Acquires Business From DPx Holdings B.V.
22 Jul 2015 //
PRESS RELEASE
Patheon Expands Stability Testing Capabilities in Greenville, NC
12 May 2015 //
PRESS RELEASE
DPx Buyout Of Specialty API Maker IRIX Is A Wrap
03 Apr 2015 //
FIERCE PHARMAMANUFACTURING
Norway`s Weifa Bets Growth On Separate API Biz
24 Mar 2015 //
FIERCE PHARMA MANUFACTURING
Patheon Acquires Agere Pharmaceuticals
10 Mar 2015 //
DCAT CONNECT
